Dhampur Bio Organics Limited (DBOL) has announced the execution of a Joint Venture Agreement with Orgonew Private Limited on June 04, 2026. This collaboration aims to develop, manufacture, market, distribute, and commercialize phyto bio-active based functional food products and other products for human consumption and usage. The Joint Venture Company (JVC) will leverage Orgonew's proprietary nano-curcumin coating platform and allied process know-how, combined with DBOL's manufacturing infrastructure and commercial reach across various sales channels. The agreement follows a Board Meeting outcome on April 20, 2026, and is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Under the terms of the agreement, DBOL will hold a 74% equity stake in the JVC, while Orgonew will hold the remaining 26%. The Board of the JVC will consist of three directors, with DBOL appointing two and Orgonew appointing one. Orgonew's shareholding in the JVC will be maintained at 26% for the first three years from the closing date, and a lock-in period of 5 years has been stipulated. Orgonew Private Limited is not related to DBOL's promoters or group companies, and the transaction is not considered a related party transaction.
